News

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil To Hold Country’s First-Ever Symposium On Medical Cannabis For Health Professionals

March 30, 2017

general_hemp_blog_images_03-01-17_ver1

Company to Educate Brazilian Medical Community on Therapeutic Uses of Cannabis, Importation Rules to Provide Patients Greater Access SAN DIEGO, March 30, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States, today

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

March 28, 2017

general-hemp-blog-medical-cannabis-17-01-10-ver1

SAN DIEGO, March 28, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Release of Revitalizing New Product – “Kannaway Energy Chews”

March 27, 2017

general-hemp-blog-hemp-plant-01-17-25-ver1

SAN DIEGO, March 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a renewed line of chewable energy supplements meant to enhance

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

March 21, 2017

general-hemp-blog-images-11-16-16-ver1

NEW YORK, March 21, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, has

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red-Carpet Event in Denver, CO

March 16, 2017

general-hemp-blog-blur-people-sitting-17-01-13-ver1

SAN DIEGO, March 16, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products is holding an exclusive Red-Carpet Event in Denver, CO., this weekend. The

Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic ‘Look At America’s Reverse-Cannabis Pipeline’

March 8, 2017

general-hemp-blog-images-01-30-17-ver1

Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government import permits for the cannabidiol (CBD)

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum

March 7, 2017

general-hemp-blog-images-11-16-16-ver1

NEW YORK, March 7, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase

Medical Marijuana, Inc. CEO Featured Speaker at California Cannabis Business Expo, Change.org Petition Seeks to Engage Trump Administration

March 6, 2017

general-hemp-blog-images-12-08-16-ver1

SAN DIEGO, March 6, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is pleased to announce that the Company’s Chief Executive Officer Dr. Stuart Titus is a featured speaker at the California Cannabis

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

March 1, 2017

general_hemp_blog_images_03-01-17_ver1 (1)

SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by

Autism Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™

March 1, 2017

general_hemp_blog_images_03-01-17_ver1

SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real